Education
About Us
Working with TipRanks
Follow Us
Ginkgo Bioworks Holdings (DNA)
NYSE:DNA
DNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.00 - $16.85
Previous CloseN/A
Volume618.97K
Average Volume (3M)1.77M
Market Cap
$652.38M
Enterprise Value$561.35M
Total Cash (Recent Filing)$473.69M
Total Debt (Recent Filing)$428.83M
Price to Earnings (P/E)―
Beta2.91
Next Earnings
Nov 17, 2025EPS Estimate
-1.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding47,089,600
10 Day Avg. Volume1,715,800
30 Day Avg. Volume1,768,922
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue2.43
Enterprise Value/Gross Profit2.96
Enterprise Value/Ebitda-1.80
Forecast
1Y Price Target
$12.50Price Target Upside7.02% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Cell Engineering PerformanceCell Engineering revenues drove the Q2 performance with 'High Value' programs up 10% year-over-year.
Cost ReductionGinkgo achieved its big cost-reduction target ahead of expectations, significantly reducing spending and making progress towards its goal of achieving positive EBITDA.
Revenue GrowthGinkgo delivered 120 active revenue-generating cell programs in Q2, which is an increase of 10% year over year.
Bears Say
Biosecurity Revenue OutlookThe company lowered its biosecurity revenue outlook for the year, citing greater uncertainty with its OUS business.
CFO ResignationCFO Mark Dmytruk is resigning from his role to pursue a new role at a different company.
Hesitancy In Life SciencesThere is hesitancy in life science tools, particularly as it relates to outsourcing, which could impact future growth.
Ginkgo Bioworks Holdings News
DNA FAQ
What was Ginkgo Bioworks Holdings’s price range in the past 12 months?
Ginkgo Bioworks Holdings lowest stock price was $5.00 and its highest was $16.85 in the past 12 months.
What is Ginkgo Bioworks Holdings’s market cap?
Ginkgo Bioworks Holdings’s market cap is $652.38M.
When is Ginkgo Bioworks Holdings’s upcoming earnings report date?
Ginkgo Bioworks Holdings’s upcoming earnings report date is Nov 17, 2025 which is in 72 days.
How were Ginkgo Bioworks Holdings’s earnings last quarter?
Ginkgo Bioworks Holdings released its earnings results on Aug 07, 2025. The company reported -$1.1 earnings per share for the quarter, beating the consensus estimate of -$1.567 by $0.467.
Is Ginkgo Bioworks Holdings overvalued?
According to Wall Street analysts Ginkgo Bioworks Holdings’s price is currently Undervalued.
Does Ginkgo Bioworks Holdings pay dividends?
Ginkgo Bioworks Holdings does not currently pay dividends.
What is Ginkgo Bioworks Holdings’s EPS estimate?
Ginkgo Bioworks Holdings’s EPS estimate is -1.24.
How many shares outstanding does Ginkgo Bioworks Holdings have?
Ginkgo Bioworks Holdings has 47,089,600 shares outstanding.
What happened to Ginkgo Bioworks Holdings’s price movement after its last earnings report?
Ginkgo Bioworks Holdings reported an EPS of -$1.1 in its last earnings report, beating expectations of -$1.567. Following the earnings report the stock price went down -8.692%.
Which hedge fund is a major shareholder of Ginkgo Bioworks Holdings?
Currently, no hedge funds are holding shares in DNA
Ginkgo Bioworks Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$12.50 (7.02% Upside)
$12.50 (7.02% Upside)
Blogger Sentiment
Neutral
DNA Sentiment 50%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 38.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
85.73%
12-Months-Change
Fundamentals
Return on Equity
-43.59%
Trailing 12-Months
Asset Growth
-24.26%
Trailing 12-Months
Company Description
Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings, Inc. is a leading biotechnology company specializing in the development of custom organisms across multiple sectors, including pharmaceuticals, agriculture, food, and industrial chemicals. The company leverages its expertise in synthetic biology to design microorganisms that can produce valuable chemicals, materials, and other products. Ginkgo Bioworks operates a platform that enables the programming of cells for a variety of applications, partnering with organizations to create tailored biological solutions.
DNA Company Deck
DNA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was generally positive, highlighting significant cost reductions, strong cash reserves, and revenue growth in key segments. However, there were concerns related to biosecurity revenue guidance and challenges in the leasing market, which were noted as potential risks.View all DNA earnings summariesDNA Revenue Breakdown
57.08% Cell Engineering
42.92% Biosecurity
DNA Stock 12 Month Forecast
Average Price Target
$12.50
▲(7.02% Upside)
Technical Analysis
Sana Biotechnology
―
Tourmaline Bio
―
Erasca
―
Rapport Therapeutics, Inc.
―
Maze Therapeutics, Inc.
―
Ownership Overview
1.07% Insiders
14.87% Mutual Funds
32.58% Other Institutional Investors
37.52% Public Companies and Individual Investors